Cargando…
p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.
Primitive neuroectodermal tumours (PNET's) or medulloblastomas are common primary brain tumours of childhood. Current treatment protocols achieve 50-60% cures. However, it has proved difficult to develop better treatment for the remaining patients because prognostic factors are not established....
Autores principales: | Jaros, E., Lunec, J., Perry, R. H., Kelly, P. J., Pearson, A. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968623/ https://www.ncbi.nlm.nih.gov/pubmed/8398711 |
Ejemplares similares
-
The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002) -
Primitive neuroectodermal kidney tumour.
por: Khan, M. S., et al.
Publicado: (1995) -
Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing’s group
por: Mezzelani, A, et al.
Publicado: (1999) -
Primitive uterine neuroectodermal tumours: Two case reports
por: Eskiyörük, İpek, et al.
Publicado: (2015) -
Primitive Neuroectodermal Tumour Invading the Inferior Vena Cava
por: Mir, Ali, et al.
Publicado: (2020)